MAPK12
MAPK12 (mitogen-activated protein kinase 12, also known as p38gamma, ERK6, SAPK3, SAPK-3 and PRKM12) is a serine/threonine kinase of the p38 MAP kinase family. It transduces extracellular stress and cytokine signals and contributes to myoblast differentiation. Browse Assay Genie's current range of MAPK12 research reagents below, or read on for the biology behind the target.
MAPK12 is a serine/threonine kinase and an essential component of the MAP kinase signal transduction pathway. It is one of the four p38 MAPKs, which mediate cellular responses to extracellular stimuli such as pro-inflammatory cytokines and physical stress, leading to direct activation of transcription factors including ELK1 and ATF2. p38 MAPKs phosphorylate a broad range of proteins, with an estimated 200 to 300 substrates each. Some targets are downstream kinases such as MAPKAPK2, which are activated by phosphorylation and in turn phosphorylate further targets.
Within this family MAPK12 has distinct roles. It acts in myoblast differentiation and in the down-regulation of cyclin D1 in response to hypoxia in adrenal cells, suggesting that it may inhibit proliferation while promoting differentiation. MAPK12 signalling also positively regulates the expansion of transient amplifying myogenic precursor cells during muscle growth and regeneration. It regulates SLC2A1 expression and basal glucose uptake in L6 myotubes, and negatively regulates SLC2A4 expression and contraction-mediated glucose uptake in adult skeletal muscle. Whereas MAPK14 stimulates c-Jun (JUN) phosphorylation, MAPK12 inhibits it, giving distinct AP-1 regulation.
MAPK12 also phosphorylates DLG1. After osmotic shock, nuclear MAPK12 increases its association with DLG1 and causes dissociation of DLG1-SFPQ complexes, a function independent of its catalytic activity that could affect mRNA processing or gene transcription. It regulates UV-induced checkpoint signalling, repair of UV-induced DNA damage and G2 arrest after gamma-radiation, and is required for normal kinetochore localisation of PLK1, preventing chromosomal instability and supporting mitotic cell viability. The protein belongs to the CMGC Ser/Thr protein kinase family, MAP kinase subfamily, and is found in the cytoplasm, nucleus and mitochondrion. The MAPK12 gene is also referred to as ERK6, and the NCBI Gene summary describes it as a signal transducer during differentiation of myoblasts to myotubes.
MAPK12 acts as a signal transducer in myoblast-to-myotube differentiation and supports expansion of myogenic precursor cells during muscle growth and regeneration.
As a p38 MAPK, MAPK12 relays cytokine and physical stress signals to transcription factors such as ELK1 and ATF2.
MAPK12 regulates UV-induced checkpoint signalling, DNA repair and G2 arrest after gamma-radiation, and supports PLK1 localisation and mitotic viability.
MAPK12 regulates SLC2A1 expression and basal glucose uptake in myotubes and negatively regulates SLC2A4 expression in adult skeletal muscle.
MAPK12 is a stress-activated serine/threonine kinase that passes signals from cytokines and physical stress to transcription factors such as ELK1 and ATF2. It also promotes myoblast differentiation, regulates DNA damage checkpoints and supports mitotic cell viability through PLK1 localisation.
MAPK12 is also called p38gamma, ERK6, SAPK3, SAPK-3 and PRKM12. HGNC classifies it in the mitogen-activated protein kinase 11-14 (p38) family, alongside MAPK11, MAPK13 and MAPK14. Its enzyme classification is EC 2.7.11.24.
Yes. The mouse and rat orthologs are both named Mapk12, which allows the kinase to be studied in rodent models of muscle differentiation and stress signalling. Check the datasheet of any product for its validated reactivity.
Other p38 family kinases, MAP kinases and MAPK-activated protein kinases with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P53778; product specifications from Assay Genie datasheets.